Home
Investors & Media
Press Releases
Press Releases
01/21/2021
The Zur Rose Group accelerates growth
01/13/2021
Zur Rose vindicated after court finds CEO Walter Oberhänsli not guilty
01/11/2021
Collaboration between Zur Rose Group and Novo Nordisk: The Zur Rose Group and Novo Nordisk combine their expertise to improve the health journeys of people with obesity
01/08/2021
TeleClinic builds on market leadership in telemedicine
12/18/2020
The healthcare platform of the future: DocMorris+ is launched
12/14/2020
Local Pharmacy Strengthening Act circumvents ECJ ruling
12/10/2020
Zur Rose Group AG: Olaf Heinrich, Head Germany, is leaving the Zur Rose Group; his successor will be Walter Hess, Head Switzerland
11/26/2020
New branding for a new vision: DocMorris
11/16/2020
Zur Rose Group: gematik awards tender for specialist e-prescription service - Zur Rose subsidiary eHealth-Tec involved as partner to IBM
11/13/2020
Allianz Care, CSS, Visana and Zur Rose Group in ground-breaking digital healthcare platform partnership
10/21/2020
Zur Rose Group accelerates growth in third quarter 2020
09/08/2020
Zur Rose and KPT together launch digital medicines assistant Medi+
08/19/2020
Zur Rose Group reinforces European market leadership by rigorously implementing the growth and platform strategy
08/17/2020
Zur Rose Group successfully concluded acquisition of the e-commerce and diabetes activities of Apotal Group
07/31/2020
Zur Rose Group successfully concluded acquisition of TeleClinic
07/17/2020
Zur Rose Group successfully completed capital increase from authorized capital and sets placement price
07/16/2020
Zur Rose Group AG resolves on capital increase from authorized Capital
07/16/2020
Zur Rose Group gives indications for half-year results
07/16/2020
Zur Rose Group acquires TeleClinic, Germany's leading telemedicine provider
06/26/2020
Zur Rose Group strengthens European market leadership through acquisition of mail-order and diabetes activities of Apotal Group
05/03/2020
Zur Rose Group: Charges in connection with mail-order of non-prescription drugs and electronic prescribing
04/23/2020
2020 Annual General Meeting of Zur Rose Group AG: Shareholders adopt all proposals
04/20/2020
Zur Rose Group AG publishes adjusted proposal for the creation of authorized share capital and withdraws the agenda item relating to the creation of additional conditional capital for the Annual General Meeting 2020
04/16/2020
Zur Rose Group starts 2020 with strong growth
04/02/2020
Zur Rose Group AG publishes invitation to the Annual General Meeting on 23 April 2020
03/26/2020
Zur Rose Group AG successfully completes the placement of CHF 175 million Convertible Bonds due 2025
03/26/2020
Zur Rose Group AG launches CHF 150 million Convertible Bonds due 2025 with up to CHF 25 million increase option
03/23/2020
COVID-19: Zur Rose is calling for an exception allowing the mail-orders for over-the-counter emergency, cold and flu medicines
03/19/2020
Zur Rose Group maintains growth momentum
03/12/2020
Zur Rose Group broadens its leadership structure and completes Group Management
01/22/2020
Zur Rose Group posts 30 per cent growth in 2019
01/13/2020
Zur Rose Group strengthens Group Management: Bernd Gschaider becomes Chief Operations Officer
12/27/2019
Zur Rose Group: Purchase price payment for medpex acquisition completed early by earn-out settlement
12/20/2019
Cooperation between Medbase and Zur Rose: The two joint ventures between Zur Rose and Medbase will commence operations at the start of the year
11/01/2019
Zur Rose Group AG increases public bond to CHF 200 million
10/29/2019
Cooperation between Migros and Zur Rose: Zur Rose and Migros open the first shop-in-shop pharmacy in French-speaking Switzerland
10/24/2019
Zur Rose Group AG successfully issues a public straight bond of CHF 180 million
10/23/2019
Zur Rose Group posts acceleration of growth in third quarter 2019
08/21/2019
Zur Rose Group grows almost 30 per cent in the first half of 2019
06/05/2019
Cooperation between Migros Group and Zur Rose: Zur Rose and Migros step up cooperation
05/23/2019
Zur Rose shareholders adopt all proposals
04/30/2019
Zur Rose Group AG publishes invitation to the Annual General Meeting of Shareholders on 23 May 2019
04/17/2019
Zur Rose Group grows 28 per cent in the first quarter of 2019
04/15/2019
The Zur Rose Group nominates three new board members
03/21/2019
The Zur Rose Group accelerates growth
03/12/2019
Zur Rose Group accelerates internationalisation
03/04/2019
Change on the Board of Directors of the Zur Rose Group
01/23/2019
Zur Rose Group realised its expansion goals in 2018 and grew by over 20 percent
01/07/2019
Zur Rose Group: Acquisition of medpex successfully concluded
01/03/2019
Zur Rose Group increases share capital
Archive
2018
2017
2016
2015
2014
2013
2012
2011
2010
12/04/2018
Further information on the rights issue
12/03/2018
Further information on the rights issue
11/29/2018
Zur Rose Group successfully concludes rights issue and announces offer price of CHF 93 per new share
11/28/2018
Zur Rose Group announces result of rights take-up
11/19/2018
Shareholders of Zur Rose Group AG approve capital increase
11/19/2018
Zur Rose Group announces the terms of the planned capital increase by way of a rights offering
11/15/2018
Zur Rose Group increases its financial targets
11/05/2018
The third Zur Rose shop-in-shop pharmacy opens at Migros headquarters in Zurich
10/31/2018
Zur Rose Group AG: Takeover of apo-rot's mail-order activities successfully completed
10/29/2018
Zur Rose Group proposes capital increase
10/18/2018
Zur Rose Group takes over e-commerce activities of medpex, Germany's third-largest online pharmacy
08/15/2018
Zur Rose Group records 30 percent sales growth in first half of 2018
08/02/2018
Zur Rose Group AG: Acquisition of the Spanish marketplace platform Promofarma
07/09/2018
Zur Rose Group AG increases public bond to CHF 115 million
06/22/2018
Zur Rose Group AG successfully issues a public bond of CHF 85 million
05/24/2018
2018 Annual General Meeting: Zur Rose shareholders adopt all proposals
05/24/2018
Zur Rose Group AG: DocMorris and apo-rot cooperate
04/18/2018
Marked surge in sales: Zur Rose Group grows 30 percent in the first quarter of 2018
03/21/2018
Zur Rose Group implements successful growth strategy
02/07/2018
Zur Rose Group AG: Statement on the draft coalition agreement in Germany: Rx mail-order ban not to be justified
01/24/2018
Double-digit growth for the Zur Rose Group in 2017
01/22/2018
Opening of more shop-in-shop pharmacies following successful launch
12/29/2017
Zur Rose Group: Takeover of Eurapon and Vitalsana successfully concluded
11/27/2017
Zur Rose Group focuses on healthcare services in Germany at its Halle location
11/23/2017
Zur Rose-Group acquires mail-order pharmacy Vitalsana
10/17/2017
Zur Rose Group speeds up its expansion programme, taking over Eurapon Pharmahandel GmbH
09/29/2017
KPT and Zur Rose are launching an innovative model for basic insurance
08/23/2017
Half-Year Results 2017: Zur Rose Group continues on growth trajectory
07/12/2017
Zur Rose Group AG announces full exercise of Greenshoe
07/11/2017
Strategic collaboration between Zur Rose and Medbase: Combination of medical and pharmaceutical competence and exclusive supply of drugs to Medbase Centres
07/06/2017
Migros and Zur Rose: Opening of the first Zur Rose shop-in-shop pharmacy in a Migros branch
07/05/2017
Zur Rose Group AG prices its IPO at CHF 140 per share and lists on SIX Swiss Exchange
06/30/2017
Zur Rose Group AG announces narrowed price range and shortens the book-building period
06/22/2017
Zur Rose Group AG launches IPO on SIX Swiss Exchange and sets price range
06/19/2017
Extraordinary General Meeting of Zur Rose Group AG: Shareholders approve creation of authorised capital and revision to Articles of Association for initial public offering (IPO)
06/08/2017
Zur Rose Group AG continues growth strategy and announces plans for listing on SIX Swiss Exchange
05/30/2017
Zur Rose Group: Notice of an Extraordinary General Meeting to be held on 19 June 2017 and Setting the stage for raising additional funds to accelerate growth
05/05/2017
Annual General Meeting of Zur Rose Group AG
04/11/2017
Zur Rose-Gruppe beschleunigt das Wachstum
02/01/2017
Zur Rose-Gruppe weiter auf Wachstumskurs; Wachstumsbeschleunigung in Deutschland
12/21/2016
Zur Rose Group AG: Stellungnahme zum Kaufangebot der Al Faisaliah Group für eine Minderheitsbeteiligung
12/11/2016
Kooperation mit Migros: Zur Rose eröffnet erste Shop-in-Shop-Apotheke der Schweiz
12/06/2016
Zur Rose: Entscheid des Verwaltungsgerichts im Kanton Aargau: Elektronische Rezeptübermittlung uneingeschränkt möglich
11/09/2016
Zur Rose Group vollzieht zweite Tranche der Kapitalerhöhung
10/19/2016
Europäischer Gerichtshof zur deutschen Festpreisbindung: Boni auf rezeptpflichtige Arzneimittel sind zulässig
10/06/2016
Zur Rose Group setzt Wachstum forciert fort
09/06/2016
Zur Rose Group: Kapitalerhöhung mit Corisol vollzogen
09/01/2016
Zur Rose Group AG: Wachstumsfinanzierung gesichert; Vanessa Frey neu im Verwaltungsrat von Zur Rose
08/29/2016
Stellungnahme zum öffentlichen Kaufangebot der Taunus Capital Management AG
08/17/2016
Zur Rose Group mit erfreulichem Ergebnis im ersten Halbjahr
08/04/2016
Erster Zur Rose-Flagshipstore mit 24/7-Abholmöglichkeit: Versandapotheke Zur Rose öffnet ihre Pforten in Bern
06/21/2016
Veränderung im Verwaltungsrat der Zur Rose Group AG
06/17/2016
Neue Ankeraktionärin für Zur Rose: Corisol-Gruppe begleitet Wachstumsstrategie mit substanzieller Beteiligung
04/12/2016
Geschäftsergebnis 2015: Überzeugendes Resultat in einem anspruchsvollen Umfeld
03/18/2016
Revision des Heilmittelgesetzes 2. Etappe vom Eidg. Parlament beschlossen
01/19/2016
Zur Rose Group bereit für neuen Wachstumsschub
11/10/2015
Zur Rose eröffnet erste Flagship-Apotheke in der Schweiz
09/29/2015
Zur Rose: Bundesgerichtsurteil: Versand von rezeptfreien Arzneimitteln wird faktisch verunmöglicht
08/24/2015
Zur Rose Group: Anspruchsvolles erstes Halbjahr 2015
04/09/2015
Zur Rose mit Ergebnissprung im Geschäftsjahr 2014
03/30/2015
Zur Rose übernimmt Mehrheitsbeteiligung an BlueCare
01/15/2015
Straffung der Organisationsstruktur: Marke «Zur Rose» künftig unter einem operativen Dach
10/16/2014
Zur Rose ist neu Kooperationspartner von MyHandicap
10/13/2014
Neuer CFO bei Zur Rose
08/21/2014
Zur Rose erzielt ein erfreuliches Halbjahresergebnis mit positiven Aussichten auf die zweite Jahreshälfte
07/07/2014
Bundesgericht zur Zusammenarbeit zwischen Ärzten mit Zur Rose im Kanton Zürich: Entschädigungen für elektronisch rezeptierende Ärzte in Zürich eingeschränkt; Entscheid betrifft 35 Ärzte
04/10/2014
Geschäftsjahr 2013 - markanter Wachstumsschub nach DocMorris-Integration; Einmaleffekte belasten Ergebnis
12/27/2013
Neue Standortstrategie: Einstellung des Logistikbetriebs in Česká Lípa per 31. März 2014
08/22/2013
Starker Wachstumsschub von Zur Rose im ersten Halbjahr 2013
06/25/2013
Zur Rose bündelt ihre Kräfte in Deutschland
04/04/2013
Solides Jahresergebnis 2012 nach strategisch bedeutender Übernahme
11/30/2012
Die Zur Rose AG hat die Obligationenanleihe über CHF 50 Mio. erfolgreich platziert und die Akquisition von DocMorris vollzogen.
11/26/2012
Zur Rose AG begibt eine Obligationenanleihe über CHF 40 Millionen mit der Möglichkeit der Erhöhung bis auf CHF 50 Millionen.
11/23/2012
Zur Rose AG informiert über den Erhalt der notwendigen kartellrechtlichen Genehmigung für die Übernahme von DocMorris.
10/25/2012
Meilenstein für Zur Rose: Akquisition der Versandapotheke DocMorris
04/12/2012
Zur Rose mit gutem Jahresergebnis 2011
11/22/2011
Schweizer Versandapotheke Zur Rose verstärkt Präsenz in der Westschweiz
10/09/2011
Zur Rose liefert als erste Schweizer Versandapotheke rezeptfreie Medikamente nach Hause
04/14/2011
Zur Rose erzielt zweitbestes operatives Ergebnis seit Bestehen
01/20/2011
Versandapotheken-Kooperation von dm drogerie markt und Zur Rose macht rezeptfreie Arzneimittel bis zu 40 Prozent günstiger
12/21/2010
Neuer CFO bei Zur Rose
09/06/2010
Zur Rose mit neu konstituiertem Verwaltungsrat
06/07/2010
Personelle Änderung in der Gruppenleitung von Zur Rose
03/31/2010
Zur Rose Gruppe setzt Wachstumskurs fort
02/10/2010
Zur Rose mit neuem Leiter für Business Unit Retail
Our Company
Main Markets & Brands
Organisation
Board of Directors
Group Management
History
Investors & Media
Press Releases
Share Information
Capital Increase
Taxable Value
Form 8937
Bond Information
Convertible Bond
Publications
Analyst Coverage
General Meeting of Shareholders
Corporate Governance
Shareholder Structure
Financial Calendar
Photos
Subscribe to Press Releases
Contact Us
Careers
Search
DE
\
EN
\
FR
Our Company
Main Markets & Brands
Organisation
Board of Directors
Group Management
History
Investors & Media
Press Releases
Share Information
Capital Increase
Taxable Value
Form 8937
Bond Information
Convertible Bond
Publications
Analyst Coverage
General Meeting of Shareholders
Corporate Governance
Shareholder Structure
Financial Calendar
Photos
Subscribe to Press Releases
Contact Us
Careers
Search
DE
\
EN
\
FR
